<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01212432</url>
  </required_header>
  <id_info>
    <org_study_id>DAPTO_CH08</org_study_id>
    <nct_id>NCT01212432</nct_id>
  </id_info>
  <brief_title>Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      Daptomycin kinetics in CRRT&#xD;
&#xD;
        -  Trial with medicinal product&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">March 2010</completion_date>
  <primary_completion_date type="Anticipated">March 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pharmacokinetics</measure>
    <time_frame>2011</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Gram-Positive Bacterial Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Daptomycin</intervention_name>
    <description>Daptomycin kinetics in CRRT</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  male or female of 18 years or older&#xD;
&#xD;
          -  females: negative pregnancy test&#xD;
&#xD;
          -  Hospitalisation in the medical ICU&#xD;
&#xD;
          -  High suspicion or evidence of Gram-positive infections requiring antibiotic therapy&#xD;
&#xD;
          -  Subjects receiving standard antibiotic treatment for Gram-positive infection&#xD;
&#xD;
          -  Evidence of renal failure&#xD;
&#xD;
          -  Clinical necessity for continuous renal replacement therapy&#xD;
&#xD;
          -  Written informed consent signed by the patient or a next of kin and an independent&#xD;
             physician in case the patient is not able to sign.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Skeletal muscle disorders or CPK levels of &gt; 2 x ULN&#xD;
&#xD;
          -  History of hypersensitivity to the drug&#xD;
&#xD;
          -  Participation in another study&#xD;
&#xD;
          -  Subjects with a history of muscle disease&#xD;
&#xD;
          -  Patients with severe liver function impairment (Child&#xD;
&#xD;
          -  Life expectancy of less than 5 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <phone>+41 (0)44 255 11 11</phone>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <study_first_submitted>September 29, 2010</study_first_submitted>
  <study_first_submitted_qc>September 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2010</study_first_posted>
  <last_update_submitted>October 15, 2010</last_update_submitted>
  <last_update_submitted_qc>October 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2010</last_update_posted>
  <responsible_party>
    <name_title>Maggiorini Marco, Prof. Dr. med.</name_title>
    <organization>University Hospital Zurich, Intensivmedizin</organization>
  </responsible_party>
  <keyword>Gram positive infection and CRRT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Gram-Positive Bacterial Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Daptomycin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

